Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regen Biologics Inc (RGBI) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Regen Biologics Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 883697.
Total stock buying since 2005: $6,642,450.
Total stock sales since 2005: $0.
Total stock option exercises since 2005: $229,078.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2009 | 1,787,020 | $6,241,042 | 0 | $0 | 62,500 | $112,500 |
2008 | 110,000 | $10,150 | 0 | $0 | 0 | $0 |
2007 | 561,500 | $35,220 | 0 | $0 | 0 | $0 |
2006 | 543,352 | $201,039 | 0 | $0 | 219,960 | $116,578 |
2005 | 182,354 | $154,999 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2009-04 | 20,300 | $59,425 | 0 | $0 | 0 | $0 |
2009-02 | 2,000 | $5,100 | 0 | $0 | 62,500 | $112,500 |
2009-01 | 1,764,720 | $6,176,517 | 0 | $0 | 0 | $0 |
2008-09 | 50,000 | $4,750 | 0 | $0 | 0 | $0 |
2008-07 | 60,000 | $5,400 | 0 | $0 | 0 | $0 |
2007-12 | 550,000 | $30,850 | 0 | $0 | 0 | $0 |
2007-07 | 11,500 | $4,370 | 0 | $0 | 0 | $0 |
2006-11 | 543,352 | $201,039 | 0 | $0 | 0 | $0 |
2006-06 | 0 | $0 | 0 | $0 | 54,990 | $29,144 |
2006-05 | 0 | $0 | 0 | $0 | 164,970 | $87,434 |
2005-07 | 182,354 | $154,999 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2009-04-14 | Mcneil Robert G | Buy | 5,000 | 2.95 | 14,750 |
2009-04-13 | Mcneil Robert G | Buy | 5,000 | 2.96 | 14,825 |
2009-04-03 | Mcneil Robert G | Buy | 5,000 | 2.92 | 14,600 |
2009-04-02 | Mcneil Robert G | Buy | 5,000 | 2.90 | 14,500 |
2009-04-01 | Mcneil Robert G | Buy | 300 | 2.50 | 750 |
2009-02-19 | Bisbee Gerald Jr (CHAIRMAN, PRESIDENT & CEO) | Buy | 2,000 | 2.55 | 5,100 |
2009-02-18 | Mcneil Robert G | Option Ex | 62,500 | 1.80 | 112,500 |
2009-01-16 | Warren Russell F Jr (10% Owner) | Buy | 285,715 | 3.50 | 1,000,002 |
2009-01-16 | Dichiara John (SR. VICE PRESIDENT) | Buy | 5,628 | 3.50 | 19,698 |
2009-01-16 | Bisbee Gerald Jr (CHAIRMAN, PRESIDENT & CEO) | Buy | 7,143 | 3.50 | 25,000 |
2009-01-16 | Umidi Brion (SR. VICE PRESIDENT & CFO) | Buy | 3,376 | 3.50 | 11,816 |
2009-01-16 | Pangia Robert W (10% Owner) | Buy | 285,715 | 3.50 | 1,000,002 |
2009-01-16 | Mcneil Robert G | Buy | 1,142,857 | 3.50 | 3,999,999 |
2009-01-16 | Steadman J Richard | Buy | 17,143 | 3.50 | 60,000 |
2009-01-16 | Timken William R | Buy | 17,143 | 3.50 | 60,000 |
2008-09-09 | Mcneil Robert G (Director) | Buy | 50,000 | .10 | 4,750 |
2008-07-29 | Rodkey William (Vice President) | Buy | 50,000 | .09 | 4,500 |
2008-07-29 | Timken William R (Director) | Buy | 10,000 | .09 | 900 |
2007-12-12 | Warren Russell F Jr (10% Owner) | Buy | 150,000 | .07 | 10,050 |
2007-12-11 | Warren Russell F Jr (10% Owner) | Buy | 400,000 | .05 | 20,800 |
2007-07-09 | Rodkey William (Vice President) | Buy | 11,500 | .38 | 4,370 |
2006-11-30 | Dichiara John (Sr. Vice President) | Buy | 10,000 | .37 | 3,700 |
2006-11-30 | Bisbee Gerald Jr (Chairman, President & CEO) | Buy | 67,568 | .37 | 25,000 |
2006-11-30 | Rodkey William (Vice President) | Buy | 13,514 | .37 | 5,000 |
2006-11-30 | Umidi Brion (Sr. VP & CFO) | Buy | 10,000 | .37 | 3,700 |
2006-11-30 | Baldwin Alan W (Director) | Buy | 27,000 | .37 | 9,990 |
2006-11-30 | Acharya Abhi (Director) | Buy | 10,000 | .37 | 3,700 |
2006-11-30 | Steadman J Richard (Director) | Buy | 135,000 | .37 | 49,950 |
2006-11-30 | Timken William R (Director) | Buy | 270,270 | .37 | 99,999 |
2006-06-01 | Steadman J Richard (Director) | Option Ex | 54,990 | .53 | 29,144 |
2006-05-24 | Mcneil Robert G (Director) | Option Ex | 164,970 | .53 | 87,434 |
2005-07-14 | Bisbee Gerald Jr (CEO) | Buy | 58,824 | .85 | 50,000 |
2005-07-14 | Umidi Brion (CFO) | Buy | 5,882 | .85 | 4,999 |
2005-07-14 | Steadman J Richard (Director) | Buy | 58,824 | .85 | 50,000 |
2005-07-14 | Timken William R (Director) | Buy | 58,824 | .85 | 50,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of RGBI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regen Biologics Inc (symbol RGBI, CIK number 883697) see the Securities and Exchange Commission (SEC) website.